1. Consideration of the major cannabinoid agonists. Advisory Council on the Misuse of Drugs (ACMD), London. Website: http://www.homeoffice.gov.uk/publications/drugs/acmd1/acmd-report-agonists?view=Binary, 2009 (accessed 10.07.10).
2. Structure-activity relationships of indole- and pyrrole-derived cannabinoids;Wiley;J. Pharmacol. Exp. Ther.,1998
3. Cannabimimetic indoles, pyrroles, and indenes: structure–activity relationships and receptor interactions;Huffman,2009
4. The Psychonaut web mapping group, M. Farre, spice drugs: cannabinoids as a new designer drugs;Mustata;Adicciones,2009
5. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Thematic paper–Understanding the ‘Spice’ phenomenon, Luxembourg, 2009, pp. 37.